Sandoz's $400m deal with US states in generic drug case gets preliminary approval
MLex Summary: Sandoz’s $400 million settlement with 48 attorneys general has been granted preliminary approval to resolve claims that it conspired to artificially inflate generic drug prices and reduce competition. See...To view the full article, register now.
Already a subscriber? Click here to view full article